A deep-learning model combining radiomics and clinicopathologic data with breast DCE-MRI improves prediction of complete pathological response after chemotherapy.
Key Details
- 1Study led by Chaowei Wu, PhD, at Cedars-Sinai Medical Center.
- 2Model integrates clinicopathologic data, shape radiomics, and retrospective pharmacokinetic quantification radiomics.
- 3Included MRI data from 1,073 breast cancer patients (2002–2016).
- 4Model achieved higher AUCs (up to 0.82 on external datasets) vs. conventional methods.
- 5Reported accuracy 69%, sensitivity 95%, specificity 59%.
- 6Early pCR prediction aids personalized treatment planning.
Why It Matters
Improved prediction of chemotherapy response using AI-driven analysis of DCE-MRI could enable more personalized and effective treatment strategies in breast cancer, potentially improving outcomes. The results show better accuracy and generalizability than existing methods across multiple datasets.
Source
AuntMinnie
Related News
•AI in Healthcare
Literature Review Highlights Gaps in Economic Evaluation of Healthcare AI
A Finnish review finds significant gaps in economic evaluation reporting of AI technologies in Western healthcare.
•AI in Healthcare
Economic Evaluations of AI in Healthcare Face Major Gaps
A Finnish review finds significant deficiencies in how studies evaluate and report the economic impact of healthcare AI.
•Health Imaging
AI Platform Triples Functional Independence in UK Stroke Patients
AI brain imaging software deployed by NHS has significantly improved stroke outcomes and functional independence rates in England.